NM_006785.4:c.1302T>C
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_006785.4(MALT1):c.1302T>C(p.Tyr434Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000026   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.0000041   (  0   hom.  ) 
Consequence
 MALT1
NM_006785.4 synonymous
NM_006785.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.118  
Publications
0 publications found 
Genes affected
 MALT1  (HGNC:6819):  (MALT1 paracaspase) This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018] 
MALT1 Gene-Disease associations (from GenCC):
- combined immunodeficiency due to MALT1 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP6
Variant 18-58733476-T-C is Benign according to our data. Variant chr18-58733476-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 566756.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000263  AC: 4AN: 152202Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
4
AN: 
152202
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251298 AF XY:  0.00000736   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
251298
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000411  AC: 6AN: 1461150Hom.:  0  Cov.: 30 AF XY:  0.00000688  AC XY: 5AN XY: 726956 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
6
AN: 
1461150
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
5
AN XY: 
726956
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
33466
American (AMR) 
 AF: 
AC: 
0
AN: 
44702
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26128
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39672
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86214
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53416
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5762
European-Non Finnish (NFE) 
 AF: 
AC: 
3
AN: 
1111426
Other (OTH) 
 AF: 
AC: 
0
AN: 
60364
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.517 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000263  AC: 4AN: 152202Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 74370 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
4
AN: 
152202
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
0
AN XY: 
74370
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
41448
American (AMR) 
 AF: 
AC: 
0
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5204
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68034
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Combined immunodeficiency due to MALT1 deficiency    Benign:1 
Oct 20, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 DS_DG_spliceai 
Position offset: 2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.